A human prion protein peptide (PrP59-91) protects against copper neurotoxicity.

PRION diseases; NEUROTOXICOLOGY; NEURODEGENERATION; SPATIAL ability

Human cellular prion protein (PrPC) is involved in several neurodegenerative disorders; however, its normal function is unknown. We report here that a synthetic peptide corresponding to the four-octarepeat sequence of the PrPC (PrP59-91) protects hippocampal neurons against copper neurotoxic effects in vivo. Using a rat bilateral intrahippocampal injection model, we found that PrP59-91 protects against copper-induced neurotoxicity, including a recovery in spatial learning performance and a reduced neuronal cell loss and astrogliosis. Previous studies from our laboratory indicated that a tryptophan (Trp) residue plays a key role in the reduction of copper(II) to copper(I); therefore several PrP59-91 fragments lacking histidine (His) and Trp residues were tested for their capacity to protect from copper toxicity. A PrP59-91 peptide lacking His residue shows as much neuroprotection as the native peptide; however, PrP59-91 without Trp residues only partially protected against copper toxicity. The neuroprotective effect not only occurs with PrP59-91, in fact a full neuroprotection was also observed using just one octamer of the N-terminal region of prion protein. We conclude that the N-terminal tandem octarepeat of the human PrPC protects neurons against copper toxicity by a differential contribution of the binding (His) and reducing (Trp) copper activities of PrP59-91. Our results are consistent with the idea that PrPC function is related to copper homeostasis.Molecular Psychiatry (2003) 8, 853-862. doi:10.1038/sj.mp.4001400 [ABSTRACT FROM AUTHOR]

Copyright of Molecular Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)